ZYPREXA Zydis
NDC 61269-650, Olanzapine, tablet, orally disintegrating, from H2-Pharma LLC.
- Product NDC
- 61269-650
- Status
- Listed
- Labeler
- H2-Pharma LLC
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021086
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/61269-650 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OLANZAPINE5 mg/1
Pharmacologic classes
Atypical Antipsychotic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 61269-650-35 | 61269065035 | 30 DOSE PACK in 1 CARTON (61269-650-35) / 1 BLISTER PACK in 1 DOSE PACK (61269-650-01) / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/b418946a-1ab4-4d89-a012-d94fc361a3c4
Use it
Look up 61269-650 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/61269-650 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 61269-650. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.